Disc Medicine : MF KOL Day May 2025

Published: 2025-05-09 15:07:05 ET IRON

Published on 05/09/2025 at 15:07

May 9, 2025

Agenda

01

John Quisel, J.D., PhD, Chief Executive Officer

02

Anemia of Myelofibrosis Disease Overview & Unmet Need

Dr. Aaron Gerds, M.D., M.S. - The Cleveland Clinic Taussig Cancer Institute

Current & Emerging Treatment Landscape

Dr. Prithviraj Bose, M.D. - The University of Texas MD Anderson Cancer Center

03

Will Savage, M.D., PhD, Chief Medical Officer

04

Pamela Stephenson, Chief Commercial Officer

05

John Quisel, J.D., PhD, Chief Executive Officer

06

Iron

Iron and heme metabolism are critical pathways in hematology with genetically-validated targets

Key points of intervention across a wide range of diseases

Heme

Spectrum of Hematologic Diseases Addressable by Disc Portfolio

Severe Rare (000s)

Moderate Prevalence (100K+)

Widely Prevalent (MMs)

Diamond-Blackfan

Erythropoietic

Beta-

Anemia of

Myelodysplastic

Sickle Cell

Polycythemia

Hereditary

IBD

CKD

Anemia

Porphyrias

Thalassemia

Myelofibrosis

Syndromes

Disease

Vera

Hemochromatosis

Anemia

Anemia

Disclaimer

Disc Medicine Inc. i published this content on May 09, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 09, 2025 at 19:06 UTC.